CIK 0001719714
- Non-accelerated filer
- Smaller reporting company
Mereo BioPharma Group plc
Sign in to watch- Ticker
- MREO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- Operating
- Phone
- +44 3330237300
- Business address
- ONE CAVENDISH PLACE, FOURTH FLOOR, LONDON, United Kingdom, W1G 0QF
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-26 | Bender Jeremy Director | Grant or award · Share Options (Right to buy) | +66,000 | 66,000 | ||
| 2026-02-26 | Bender Jeremy Director | Grant or award · Deferred Restricted Stock Units | +117,533 | 117,533 | ||
| 2025-02-05 | Bender Jeremy Director | Grant or award · Share Options (Right to buy) | +55,000 | 55,000 | ||
| 2025-02-05 | Bender Jeremy Director | Grant or award · Deferred Restricted Stock Units | +16,768 | 16,768 | ||
| 2024-06-17 | Bender Jeremy Director | Grant or award | +12,550 | $3.99 | $50K | 12,550 |
| 2024-02-08 | Bender Jeremy Director | Grant or award · Share Options (Right to buy) | +45,000 | 45,000 | ||
| 2024-02-08 | Bender Jeremy Director | Grant or award · Deferred Restricted Stock Units | +16,361 | 16,361 |
Page 1 of 1 · 7 trades